Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Chimeric Therapeutics Ltd
CHMCurrent price
0.015 AUD
-0.001 AUD (-6.25%)
Last closed
0.016 AUD
Company
www.chimerictherapeutics.com
ISIN
AU0000121576
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
13 226 719 AUD
Yield for 12 month
-50.00 %
1Y
3Y
5Y
10Y
15Y
CHM
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The company was incorporated in 2020 and is based in Carlton, Australia. Address: 62 Lygon Street, Carlton, VIC, Australia, 3053
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.89 AUDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+4 446 081 AUD
Current Quarter
–
Last Quarter
+5 412 609 AUD
Current Year
-3 871 AUD
Last Year
+3 493 511 AUD
Current Quarter
–
Last Quarter
+4 932 277 AUD
Key Figures CHM
1 year
3 years
5 years
10 years
EBITDA
-11 207 865 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-41.05 %
PEG Ratio
–
Return On Equity TTM
-308.21 %
Wall Street Target Price
0.89 AUD
Revenue TTM
8 244 238 AUD
Book Value
0.003 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
264.5 %
Dividend Yield
–
Gross Profit TTM
4 446 082 AUD
Earnings per share
-0.03 AUD
Diluted Eps TTM
-0.03 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-149.97 %
Dividend Analytics CHM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CHM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CHM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
8325.1447
Price Sales TTM
1.6044
Enterprise Value EBITDA
-2.1391
Price Book MRQ
0.9669
Financials CHM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CHM
For 52 weeks
0.015 AUD
0.046 AUD
50 Day MA
0.017 AUD
Shares Short Prior Month
–
200 Day MA
0.024 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart